Evidence map›Paper›PMID 39338271›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Biologically Synthesized Gold Nanoparticles with Enhanced Antioxidant and Catalytic Properties.

Melinda David, Teodor A Enache, Lucian Barbu-Tudoran, Camelia Bala, Monica Florescu

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Melinda DavidLaboratory for Quality Control and Process Monitoring, University of Bucharest, 4-12 Elisabeta Blvd., 030018 Bucharest, Romania.ORCID 0000-0002-2971-4547
Teodor A EnacheNational Institute of Material Physics, Atomistilor 405A, 077125 Magurele, Romania.ORCID 0000-0002-1848-6753
Lucian Barbu-TudoranElectron Microscopy Center "C. Craciun", Biology and Geology Faculty, Babes-Bolyai University Cluj-Napoca, 4-6 Clinicilor Str., 400006 Cluj-Napoca, Romania.ORCID 0000-0003-0360-016X
Camelia BalaLaboratory for Quality Control and Process Monitoring, University of Bucharest, 4-12 Elisabeta Blvd., 030018 Bucharest, Romania.ORCID 0000-0002-9481-3496
Monica FlorescuDepartment of Fundamental, Prophylactic and Clinical Disciplines, Faculty of Medicine, Transilvania University of Brasov, Str. Universitatii no. 1, 500068 Brasov, Romania.ORCID 0000-0002-1467-3113

Funding

the Romanian Ministry of Education and Research, CNCS - UEFISCDI PN-III-P1-1.1-PD-2019-1285
6 · The paper itself

Abstract

Increasing levels of reactive oxygen species generate oxidative stress in the human body that can lead to various medical conditions. The use of nanomaterials exhibiting antioxidant properties may prevent these effects. The biological synthesis of metallic nanoparticles using plant extracts with antioxidant properties can offer benefits due to their active compounds. The used extracts contained reducing and stabilizing agents, which were shown to be transferred onto the gold nanoparticles, functionalizing them. Herin, we report a gold nanoparticle synthesis by eco-friendly biological methods (b-AuNPs) using extracts of sea buckthorn, lavender, walnuts, and grapes, obtained through ultrasound-assisted extraction and pressure-enhanced extraction. The obtained b-AuNPs were characterized by UV-Vis and FTIR spectroscopies and visualized using transmission electron microscopy. The catalytic and scavenging effect of the b-AuNPs towards H

Indexed as

biological synthesisenhanced antioxidant propertiesenhanced catalytic propertiesmetallic nanoparticles

Identifiers

PMID39338271
PMCPMC11434865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.